Takeda Pharmaceutical Co Ltd
OTC:TKPHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
|
L
|
London Stock Exchange Group PLC
XMUN:LS4C
|
UK |
|
Millicom International Cellular SA
F:M4M1
|
LU |
|
N
|
Netlist Inc
F:XAB
|
US |
|
T
|
Terreno Realty Corp
F:T37
|
US |
|
C
|
Comerica Inc
F:CA3
|
US |
|
V
|
Victory Square Technologies Inc
F:6F6
|
CA |
|
A
|
ANI Pharmaceuticals Inc
F:BSFA
|
US |
|
Shanghai Electric Group Co Ltd
F:USR
|
CN |
|
Elecnor SA
F:EK5
|
ES |
|
H
|
Hera SpA
F:HE9
|
IT |
|
C
|
Cronos Group Inc
XMUN:7CI
|
CA |
Wall St Price Targets
TKPHF Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKPHF is 39.29 USD with a low forecast of 32.49 USD and a high forecast of 50.66 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKPHF's stock price target?
Price Target
39.29
USD
According to Wall Street analysts, the average 1-year price target for TKPHF is 39.29 USD with a low forecast of 32.49 USD and a high forecast of 50.66 USD.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 44%.
